Progress Against Melanoma
1970–1979
Progress Against Melanoma 1970– : Hereditary syndrome linked to increased melanoma risk
Progress Against Melanoma 1980–1989
Progress Against Melanoma 1980– s–1990s: Research links sun exposure to melanoma risk
Progress Against Melanoma 1980–1989 Mid-1980s: Less extensive surgery found effective for removing melanoma tumors
Progress Against Melanoma 1980– : Personalized immunotherapy can shrink some melanoma tumors
Progress Against Melanoma 1990–1999
Progress Against Melanoma 1990– : Sentinel lymph node biopsy introduced to assess the spread of melanoma to nearby lymph nodes
Progress Against Melanoma 1990– : Interferon approved as first adjuvant treatment
Progress Against Melanoma 1990– : Second immunotherapy drug approved for melanoma
Progress Against Melanoma 2000–Present
Progress Against Melanoma 2000–Present 2001: New staging system helps doctors determine prognosis, select best melanoma treatments
Progress Against Melanoma 2000–Present 2002: Genetic ''fingerprints'' of melanoma tumors differ widely
Progress Against Melanoma 2000–Present 2005: Melanoma, other skin cancers increasing in young people
Progress Against Melanoma 2000–Present 2008: Microscopic examination improves accuracy of skin cancer screening
Progress Against Melanoma 2000–Present 2009: Melanoma incidence continues to rise in the U.S. 2009: Researchers begin mapping the melanoma genome
Progress Against Melanoma 2000–Present 2010: First drug shown to improve survival for patients with advanced melanoma 2011: Second targeted drug extends survival for advanced melanoma 2010: Indoor tanning declared a carcinogen
Progress Against Melanoma Five-Year Survival Source: National Cancer Institute
Progress Against Melanoma Mortality Source: National Cancer Institute
Progress Against Melanoma New Cases Source: National Cancer Institute
Visit CancerProgress.Net for an interactive timeline of progress against a range of common cancers CancerProgress.Net is a project of the American Society of Clinical Oncology, which represents nearly 30,000 physicians who treat people with cancer and research new cures